DBVT · DBV Technologies S.A. · Executive Compensation
Market Cap
$748.84M
Shares
62.85M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Daniel Tassé | Chief Executive Officer and Director | $1,472,146 |
| Pharis Mohideen | Chief Medical Officer | $820,762 |
| Virginie Boucinha | Chief Financial Officer | $458,450 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Daniel Tassé | Chief Executive Officer and Director | $2,440,486 |
| Pharis Mohideen | Chief Medical Officer | $1,279,518 |
| Sébastien Robitaille | Former Chief Executive Officer | $344,286 |
| Virginie Boucinha | Chief Financial Officer | $234,630 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Daniel Tassé | Chief Executive Officer and Director | $2,787,640 |
| Pharis Mohideen | Chief Medical Officer | $1,076,807 |
| Sébastien Robitaille | Former Chief Executive Officer | $501,628 |
| Virginie Boucinha | Chief Financial Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Daniel Tassé | Chief Executive Officer and Director | $2,430,966 |
| Pharis Mohideen | Chief Medical Officer | $1,196,778 |
| Sébastien Robitaille | Chief Financial Officer | $612,091 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Daniel Tassé | Chief Executive Officer and Director | $2,062,135 |
| Pharis Mohideen | Chief Medical Officer | $1,032,851 |
| Sébastien Robitaille | Chief Financial Officer | $509,778 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Sébastien Robitaille | Chief Financial Officer | $724,403 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel Soland | Board of Directors | Resigned | 2025-10-30 |
| Philina Lee | member of the Compensation Committee | Appointed | 2025-10-30 |
| Philina Lee | Board of Directors | Appointed | 2025-10-30 |
| Daniel Soland | member of its Board of Directors | Resigned | 2025-09-18 |
| Virginie Boucinha | Chief Financial Officer | Appointed | 2023-10-16 |